Azienda Ospedaliera Universitaria Integrata Verona
Clinical trials sponsored by Azienda Ospedaliera Universitaria Integrata Verona, explained in plain language.
-
Needle vs knife: new study tests less invasive treatment for rare pancreatic tumor
Disease control OngoingThis study compares two treatments for pancreatic insulinoma, a rare pancreatic tumor that causes low blood sugar. Researchers are testing whether a less invasive procedure using a needle to deliver heat (radiofrequency ablation) is as safe and effective as traditional surgery. T…
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
10-Year heart study aims to predict Who's at risk
Knowledge-focused OngoingThis study is collecting information from about 1,000 patients who had a heart artery test in Verona, Italy, between 2010 and 2024. Researchers will track these patients for up to 10 years to see if the results from a special artery measurement taken during their initial test can…
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
New test could better predict pancreatic tumor danger
Knowledge-focused OngoingThis study aims to see if checking for the loss of two specific proteins (ATRX and DAXX) in small biopsy samples taken before surgery can help doctors better predict how aggressive a pancreatic neuroendocrine tumor will be. Researchers will follow 100 patients with these non-func…
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC